FCI Nunchaku® is a pushed silicone self-retaining bicanalicular nasolacrimal intubation stent that acts like a conformer, allowing tears to be drained by capillarity. The metallic guides are located inside the lumen, not as an extension of the stent as in conventional intubation sets. Therefore, no nasal retrieval is needed.

Masterka® is FCI innovative solution for treatment of congenital nasolacrimal duct obstruction resistant to probing. Especially indicated for children, this intubation has no metallic probe or suture attached to it and is therefore not pulled out of the nose. The insertion procedure is easy and less traumatic than with conventional intubation sets.

LacriJet® is FCI latest and exclusive preloaded & self-retaining monocanalicular nasolacrimal intubation indicated for epiphora, congenital nasolacrimal duct obstruction and canalicular laceration.

Precivia®* simplifies intravitreal injections by making the procedure faster and more predictable. Its unique design presents a guide tube accurately oriented to ensure a fixed injection angle of 28°, a fixed distance at 3.5 mm from the limbus, and a controlled depth.

EZYPOR® is FCI ultimate high density polyethylene orbital implant with a patented innovative suturing platform, indicated for enucleation, evisceration and secondary implantation. EZYPOR® has a smooth anterior suturing surface with 8 suture tunnels allowing multiple suturing options.

Dry eye is a condition caused by the production of low quantity or poor quality of tears resulting in eye irritation and vision problems.
Discover our Dry Eye treatments

Ritleng®+ is FCI latest autostable bicanalicular nasolacrimal intubation consisting of a silicone tube connected at each extremity to a PEEK thread guide to reduce operating time and trauma for the patients. The intubation is self-retaining thanks to two wider silicone portions on the silicone tube. The surgical procedure is similar to the conventional Ritleng® lacrimal intubation and involves the use of Ritleng® instruments.

EZYPOR® is FCI ultimate high density polyethylene orbital implant indicated for enucleation, evisceration and secondary implantation. EZYPOR® comes with a unique and patented smooth anterior suturing platform with 8 suture tunnels, allowing for multiple suturing options.